🇺🇸 FDA
Patent

US 11833160

Ursodeoxycholic acid derivatives as HDAC inhibitors for the treatment of polycystic diseases

granted A61KA61K31/575A61K31/58

Quick answer

US patent 11833160 (Ursodeoxycholic acid derivatives as HDAC inhibitors for the treatment of polycystic diseases) held by UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA
Grant date
Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/575, A61K31/58, A61P, A61P1/04